CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Stock Performance
About CardioGenics
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Articles
- Five stocks we like better than CardioGenics
- What is a buyback in stocks? A comprehensive guide for investors
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
